North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Dexamethasone
found
33 matches
Formulary items
17 matches
Non-formulary items
1 match
Open monograph to display formulary status
BNF Category
Ciprofloxacin &
Dexamethasone
(Ciprodex
®
)
Ear, nose and oropharynx - Anti-infective preparations - 12.01.01
Dexamethasone
Endocrine system - Glucocorticoid therapy - 06.03.02
Dexamethasone
0.05% with framycetin 0.5% ear drops
(Sofradex
®
)
Ear, nose and oropharynx - Anti-inflammatory preparations - 12.01.01
Dexamethasone
0.05%, framycetin sulf. 0.5%, gramicidin 0.005% eye drops
(Sofradex)
Eye - Corticosteroids - 11.04.01
Dexamethasone
0.1% eye drops
(Maxidex
®
)
Eye - Corticosteroids - 11.04.01
Dexamethasone
0.1% Preservative-free
Eye - Corticosteroids - 11.04.01
Dexamethasone
0.1% with neomycin 0.5% spray
(Otomize
®
)
Ear, nose and oropharynx - Anti-inflammatory preparations - 12.01.01
Dexamethasone
3.3mg in 1ml and 6.6mg in 2ml
(injection )
Endocrine system - Glucocorticoid therapy - 06.03.02
Dexamethasone
700 microgram intravitreal implant
(Ozurdex
®
)
Eye - Corticosteroids - 11.04.01
Dexamethasone
Phosphate
Musculoskeletal and joint diseases - Local corticosteroids injections - 10.01.02.02
Dexamethasone
with Neomycin and Polymyxin B sulphate
(Maxitrol
®
)
Eye - Corticosteroids - 11.04.01
Carfilzomib
(Kyprolis
®
)
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Daratumumab
(Darzalex
®
)
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Isatuximab
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Lenalidomide
Malignant disease and immunosuppression - Lenalidomide, pomalidomide, and thalidomide - 08.02.04
Panobinostat
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Selinexor
(Nexpovio
®
)
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Non Formulary
BNF Category
Melphalan flufenamide
Malignant disease and immunosuppression - Alkylating drugs - 08.01.01
Links
Link to Drug Section
Link to document
MHRA Alert (Oct 2014): Dexamethasone 4 mg/ml injection (Organon Laboratories Limited): reformulation with changes in name, concentration, storage conditions, and presentation (06.03.02)
NICE TA229 Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion (11.04.01)
NICE TA460 Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.02)
NICE TA460 Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.01)
NICE TA586: Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib (08.02.04)
NICE TA587: Lenalidomide plus dexamethasone for previously untreated multiple myeloma (08.02.04)
NICE TA658: Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma (08.01.05)
NICE TA695: Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma (08.01.05)
NICE TA824: Dexamethasone intravitreal implant for treating diabetic macular oedema (11.04.01)
NICE TA870: Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (08.01.05)
NICE TA897: Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma (08.01.05)
NICE TA917: Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable (08.01.05)
NICE TA968:Melphalan flufenamide with dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) (08.01.01)
NICE TA970: Selinexor with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatments (08.01.05)
NICE TA974: Selinexor with bortezomib and dexamethasone for previously treated multiple myeloma (08.01.05)
